February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
January 27, 2025 China’s DeepSeek Challenges U.S. AI Giants, Shakes Tech Markets
January 23, 2025 Trump’s AI Revolution: Stargate Initiative Sparks Economic Surge
Tesla: Navigating Challenges Amid Accelerating Innovation Shifts
Nvidia: Unlocking Hidden Catalysts Driving Future Value
Amazon's Q4 Outlook: Navigating Tariffs and Growth Potential
A. O. Smith Corporation: Approaching Value but Risks Persist
Microsoft Demonstrates Resilient Growth Amid Market Challenges
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
Esperion Therapeutics (ESPR) stock forecast for 2025
Updated: February 6, 2025 (05:06)
Sector: HealthcareThe share price of Esperion Therapeutics, Inc. (ESPR) now
50/200 Day Moving Average: $2.409 / $2.196
This figure corresponds to the Average Price over the previous 50/200 days. For Esperion Therapeutics stocks, the 50-day moving average is the resistance level today.
For Esperion Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Esperion Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Esperion Therapeutics stock price in 2025. How much will one Esperion Therapeutics share be worth in 2025? Is it worth taking profit / loss on ESPR stock now or waiting? What are analysts' forecasts for Esperion Therapeutics stock?
We forecast Esperion Therapeutics stock performance using neural networks based on historical data on ESPR stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Esperion Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Esperion Therapeutics analysts is $7.13. Today 200 Day Moving Average is the resistance level (2.196 $). 50 Day Moving Average is the resistance level (2.409 $).
Historical and forecast chart of Esperion Therapeutics, Inc. stock
The chart below shows the historical price of Esperion Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ESPR stock price can be found in the table below.
Esperion Therapeutics is a publicly available US pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated LDL-C levels.
Esperion Therapeutics (ESPR) Forecast for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Mar | 2.19 | 1.91 | 2.73 | 30.06 % |
Apr | 2.32 | 2.07 | 2.55 | 18.84 % |
May | 2.66 | 2.16 | 3.02 | 28.37 % |
Jun | 1.84 | 1.60 | 2.01 | 20.48 % |
Jul | 1.64 | 1.28 | 1.85 | 30.91 % |
Aug | 1.99 | 1.52 | 2.34 | 34.87 % |
Sep | 2.19 | 1.67 | 2.59 | 35.64 % |
Oct | 2.42 | 2.25 | 2.90 | 22.51 % |
Nov | 2.06 | 1.72 | 2.20 | 21.54 % |
Dec | 1.42 | 1.32 | 1.56 | 15.79 % |
Esperion Therapeutics information and performance
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US
Market capitalization of the Esperion Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ESPR shares in the company outstanding by the market price of one share.
EBITDA of Esperion Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Esperion Therapeutics price target for 2025 by month
Target values for the price of one Esperion Therapeutics share for Mar 2025.
In Mar, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 30.056% volatility is expected.
Pessimistic target level: 1.91
Optimistic target level: 2.73
Target values for the price of one Esperion Therapeutics share for Apr 2025.
In Apr, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.842% volatility is expected.
Pessimistic target level: 2.07
Optimistic target level: 2.55
Target values for the price of one Esperion Therapeutics share for May 2025.
In May, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 28.370% volatility is expected.
Pessimistic target level: 2.16
Optimistic target level: 3.02
Target values for the price of one Esperion Therapeutics share for Jun 2025.
In Jun, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 20.479% volatility is expected.
Pessimistic target level: 1.60
Optimistic target level: 2.01
Target values for the price of one Esperion Therapeutics share for Jul 2025.
In Jul, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 30.909% volatility is expected.
Pessimistic target level: 1.28
Optimistic target level: 1.85
Target values for the price of one Esperion Therapeutics share for Aug 2025.
In Aug, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 34.867% volatility is expected.
Pessimistic target level: 1.52
Optimistic target level: 2.34
Target values for the price of one Esperion Therapeutics share for Sep 2025.
In Sep, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 35.641% volatility is expected.
Pessimistic target level: 1.67
Optimistic target level: 2.59
Target values for the price of one Esperion Therapeutics share for Oct 2025.
In Oct, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.505% volatility is expected.
Pessimistic target level: 2.25
Optimistic target level: 2.90
Target values for the price of one Esperion Therapeutics share for Nov 2025.
In Nov, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 21.538% volatility is expected.
Pessimistic target level: 1.72
Optimistic target level: 2.20
Target values for the price of one Esperion Therapeutics share for Dec 2025.
In Dec, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 15.793% volatility is expected.
Pessimistic target level: 1.32
Optimistic target level: 1.56
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.